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Prenatal and perinatal insults are implicated in the aetiology of psychotic disorders but the 
consistency and magnitude of their associations with psychosis have not been updated for 
nearly two decades. 
 
Methods 
Independent Web of Science search (up to 20th July 2019) and data extraction according to 
EQUATOR/PRISMA guidelines to identify cohort and case-control studies examining the 
association (odds ratio, OR) between prenatal/perinatal factors and any ICD/DSM non-organic 
psychotic disorder with a healthy comparison group. Random-effects pairwise meta-analyses, 
Q statistics, I2 index, sensitivity analyses, and assessment of study quality and publication 




152 studies relating to 98 factors were included. Significant risk factors were: maternal ages 
<20 (OR=1.17) and 30–34 (OR=1.05), paternal age <20 (OR=1.31) and >35 (OR=1.28), any 
maternal (OR=4.60) or paternal (OR=2.73) psychopathology, maternal psychosis (OR=7.61) 
and affective disorder (OR=2.26), ³3 pregnancies (OR=1.30), herpes simplex 2 (OR=1.35), 
maternal infections not otherwise specified (NOS) (OR=1.27), suboptimal number of antenatal 
visits (OR=1.83), winter (OR=1.05) and winter/spring (OR=1.05) season of birth in northern 
hemisphere, maternal stress NOS (OR=2.40), famine (OR=1.61), any famine/nutritional 
deficits in pregnancy (OR=1.40), maternal hypertension (OR=1.40), hypoxia (OR=1.63), 
ruptured (OR=1.86) and premature rupture (OR=2.29) of membranes, polyhydramnios 
(OR=3.05), definite obstetric complications NOS (OR=1.83), birthweights <2000g (OR=1.84), 
<2500g (OR=1.53), 2500–2999g (OR=1.23), birth length <49cm (OR=1.17), small for 
gestational age (OR=1.40), premature birth (OR=1.35) and congenital malformations 
(OR=2.35). Significant protective factors were: maternal ages 20–24 (OR=0.93) and 25–29 




Numerous prenatal and perinatal factors are associated with the later onset of psychosis. The 
updated knowledge emerging from this study may refine our understanding of psychosis 






The neurodevelopmental model of psychosis1,2 was first born into existence over 30 years 
ago, positing that genetic predisposition, combined with prenatal and perinatal insults, 
programmed the developing brain towards later psychosis3. The central tenet of this “two-hit” 
model was that the initial insult occurs in utero, prompting cascades of aberrant 
neurodevelopmental processes and alterations in neural architecture and function, leading to 
a trajectory of vulnerability to later insults during puberty or adolescence4,5. In a refinement of 
these early and simplistic models, the current Developmental Risk Factor Model6,7 accounts 
for many epidemiological, genetic, neuroimaging and environmental factors implicated or 
associated with the psychosis spectrum8.  
 
Although the pre- and perinatal environment—and associated insults—maintained their 
proposed position of importance over this aetiopathological journey, their specific contribution 
to the emergence of psychosis has remained elusive. The earliest findings reported that 
periventricular bleeding and ischemic injury, hypoxia, and winter birth were more common in 
affected discordant twins and singletons with schizophrenia2,9-12. Later, as large-scale cohort 
studies came to fruition, it became clear that low birthweight, maternal infection during 
pregnancy, maternal exposure to severe stress, such as famine or genocide, and many other 
obstetric complications were positively associated with offspring psychosis13-23. A 
comprehensive meta-analysis of obstetric complications was last conducted in 200219, 
showing that pregnancy complications (such as bleeding, diabetes, rhesus incompatibility), 
abnormal foetal growth and development (low birthweight, congenital malformations) and 
delivery complications (such as asphyxia, emergency caesarean) were all associated with 
schizophrenia.  
 
Since that time, prospective studies have established the long-term consequences of pre- and 
perinatal hazards on exposed infants24,25. These, and also umbrella reviews26 (meta-analyses 
of meta-analyses) have revealed that numerous pre- and perinatal risk factors are associated 
not only with psychosis but with a range of cognitive and neurological abnormalities as well 
as other psychiatric and neurodevelopmental disorders27-32; neuroimaging studies have 
demonstrated that when such infants reach adulthood they show an excess of brain structural 
and dopaminergic abnormalities reminiscent of those found in patients with schizophrenia25,33. 
Despite this substantial and accumulating literature, no comprehensive meta-analysis of pre- 
and perinatal risk factors for psychosis has been published in nearly 20 years19,22,23.  
 
Having robust, updated, publication bias-corrected estimates of these associations would 
advance aetiopathological knowledge, inform multivariable individualised risk prediction 
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models34,35 and facilitate identification of potentially modifiable factors that could be the target 
of preventive strategies. To fill this gap in knowledge, we conducted a systematic review and 
meta-analysis to quantify the consistency and magnitude of the associations between prenatal 
and perinatal risk factors and all non-organic psychotic disorders (including non-




The study protocol was registered on PROSPERO (CRD42017079261) and followed 
EQUATOR Meta-analysis of Observational Studies in Epidemiology (MOOSE)36 (eTable 1) 
and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)37 
guidelines (eTable 2). 
 
Search Strategy and Selection Criteria 
In a multistep literature search, we first searched the Web of Science (including 
MEDLINE/Pubmed) database to identify original studies examining the association between 
prenatal and perinatal risk factors (exposures) and psychotic disorders (outcomes), published 
in English from database inception to 20th July 2019 (see details in eMethods 1). Second, 
additional records were identified through manual searches of the reference lists of included 
articles.  
 
Articles were initially screened on the basis of titles and abstracts. Full texts of potentially 
eligible articles were then scrutinised against these inclusion criteria: (i) observational (case-
control and cohort) primary studies published in peer-review journals that examined the 
association between prenatal and perinatal risk or protective factors (see below) and psychotic 
disorders, (ii) definition of any non-organic psychotic disorder according to the ICD or the DSM, 
(iii) inclusion of a comparison group of non-psychotic (preferably healthy) controls, (iv) enough 
data available to perform the analyses (i.e. raw binary data or pre-calculated odds ratio, see 
below), (v) non-overlapping datasets. Exclusion criteria were: (i) reviews, meta-analyses, 
abstracts/conference proceedings, and study designs other than the above (i.e. cross-
sectional studies), and (ii) overlapping datasets. When two articles presented overlapping 
datasets (i.e. analyses of the same subjects/samples) on the same factor, the article with the 
largest dataset, most similar risk/protective factor definition compared to other studies, or 
longest follow-up period was retained for that risk factor. Risk or protective factors were 
considered eligible if they occurred within the prenatal or perinatal period as defined by the 
World Health Organization; prenatal factors were those operating from the time of conception 
to birth; perinatal factors were those operating from 22 completed weeks (154 days) of 
gestation to seven completed days after birth38. Because distinctions between prenatal vs 
perinatal factors are arbitrary, we did not attempt to separate these factors in this way. 
Importantly, selection of factors was pragmatic with no assumption that they were pure 
environmental factors. Consequently, some of them (e.g. familial psychopathology) could 
include composite genetic, environmental effects, or their interaction.   
 
Outcome Measures and Data Extraction 
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Literature search, data selection and data extraction were performed independently by at least 
two investigators (CD, GS, AE, AdM, UP, VR-C, MB, GC, CS, GCr, AI) and discrepancies 
resolved by consensus with a senior researcher (PFP). Extracted variables included: first 
author, publication year, study type, sample size, type of psychotic diagnosis (non-affective 
psychoses/schizophrenia spectrum disorders, affective psychoses; eTable 3) and diagnostic 
instrument (DSM or ICD and version), the risk/protective factor and measure of association 
(primary outcome). Our preference for the latter was the binary data needed to calculate an 
odds ratio (OR). When not available, we extracted reported OR or Risk Ratios (preferably 
unadjusted for any covariates) with 95% confidence intervals (CI), or means and standard 
deviations, and transformed them to OR (eMethods 2). Specifically, risk ratios were 
considered equivalent to OR given the low incidence of psychotic disorders. When only means 
and standard deviations for each group were available, we assumed a continuous probability 
distribution and derived the frequencies of individuals needed in each group to calculate the 
OR of interest (eMethods 2). No other imputations or transformations were conducted. 
Risk/protective factor data were initially extracted as defined in the original papers. When 
possible, factors were then pooled into larger categories using established definitions (e.g. 
World Health Organization) and through consultation with expert clinician-researchers in 
perinatal psychiatry (PD, MM). The factors were clustered for reporting (i.e. not meta-
analytical) purposes into four descriptive categories: parental and familial factors, pregnancy 
factors, labour and delivery factors, and foetal growth and development factors. 
 
Risk of Bias Assessment 
Bias was assessed using a modified version of the Newcastle-Ottawa Scale for cohort and 
case-control studies, in line with our previous meta-analyses29. Studies were awarded a 
maximum of nine points on items related to the selection of the cohort/cases, comparability of 
exposed and non-exposed groups, ascertainment of exposure and outcome, and adequacy 
of follow-up (eMethods 3). Risk of bias scores were used only as covariate in meta-regression 
analyses (see below). 
 
Statistical Analysis 
For each risk/protective factor (e.g. “exposure to toxoplasma”) with data from at least 3 
independent samples, we conducted a quantitative random-effects meta-analysis to 
summarise the results39. The main outcome of the meta-analysis was the pooled odds ratio 
(OR) of the risk/protective factor. OR greater than 1 indicated that the factor was associated 
with increased likelihood of psychotic disorders (risk factor), whereas OR lower than 1 
indicated that the factor was associated with decreased likelihood of psychotic disorders 
(protective factor). We also calculated the 95% CI and the P-value of the OR. All risk factors 
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were operationalised as dichotomous exposures (present vs absent). For ordinal variables, 
each ordinal level was vs all other levels (i.e. no referent group). To assess between-study 
heterogeneity, we looked at the I2 index40 (I2>50% is commonly considered to indicate serious 
heterogeneity), and conducted the Q test (P<.05 might indicate potential heterogeneity). To 
assess publication bias, we looked for asymmetry in the funnel plots, used the Duval and 
Tweedie’s trim-and-fill41,42 method to estimate potential unpublished studies with negative 
results, and conducted the Egger’s test43 (P<.05 might indicate potential publication bias). 
When the trim-and-fill method estimated one or more potential unpublished studies, we 
recalculated the OR and its 95% CI with these estimated studies. Significant risk factors did 
not ‘survive’ publication bias adjustment if the 95% CI became non-significant (i.e. included 
the null hypothesis, OR=1) following the trim-and-fill procedure. For those factors with serious 
heterogeneity and at least 10 samples, we conducted meta-regressions by risk of bias scores 
and study design. Sensitivity analyses of the core findings were conducted after excluding 
studies that ascertained exposure using retrospective recall/questionnaires (e.g. maternal 
recall after the outcome was known). Statistical significance was set at P<.05 (two-tailed) and 








Overall, 14,799 records were identified, 440 full-texts were screened and 152 were eligible for 
inclusion (Figure 1). The 152 included articles were published between 1977 and July 2019 
(see eTable 4 for details of included studies). Study sample sizes ranged from 52 to 
29,209,710 and bias (quality) assessment scores ranged from 4–9 (eTable 4). The included 
studies reported on 98 putative risk/protective factors for psychotic disorders (see eTable 5 
for further risk factor definitions).  
 
Meta-Analytic Results 
Overall, 30 risk factors (and 4 more that we discarded due to potential publication bias) and 5 
protective factors were associated with psychotic disorders (see Tables 1–4 for full meta-
analytic, publication bias and heterogeneity results). 
 
Parental & Familial Factors (Table 1) 
Maternal ages <20 (OR=1.17) or 30–34 (OR=1.05) were statistically significant risk factors, 
while ages 20–24 (OR=0.93) and 25–29 (OR=0.92) were statistically significant protective 
factors. Both young and later paternal age were statistically significant risk factors: <20 years 
(OR=1.31) and >35 (OR=1.28). Maternal nulliparity was a statistically significant protective 
factor (OR=0.91), while 3 or more previous pregnancies was a statistically significant risk 
factor (OR=1.30). Familial psychopathology, including any maternal (OR=4.60) or paternal 
(OR=2.73) psychopathology, maternal psychosis (OR=7.61) and maternal affective disorder 
(OR=2.26) were statistically significant risk factors. We did not detect publication bias for these 
factors. 
 
Pregnancy Factors (Table 2) 
Exposure to infective agents, including herpes simplex (HSV) type 2 (OR=1.35), toxoplasma 
(OR=1.30) and maternal infections not otherwise specified (NOS) (OR=1.27) were all 
statistically significant risk factors. Suboptimal number of antenatal care visits (OR=1.83), 
winter (OR=1.05) and winter/spring season of birth in northern hemisphere (OR=1.05), 
maternal stress NOS (OR=2.40), famine (OR=1.61), or any famine or nutritional deficits during 
pregnancy (OR=1.40) were all statistically significant risk factors. Obstetric complications, 
including maternal hypertension (OR=1.40), hypoxia (OR=1.63), ruptured membranes 
(OR=1.86) and particularly premature rupture of membranes (OR=2.29), polyhydramnios 
(OR=3.05), obstetric complications NOS (OR=1.52), “definite” obstetric complications NOS 
(defined by the Lewis-Murray Scale9,44) (OR=1.83) and blood loss during pregnancy 
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(OR=1.54) were all significant risk factors. We detected potential publication bias for exposure 
to toxoplasma (trim-and-fill corrected OR=1.25, 95%CI 0.98–1.58), obstetric complications 
NOS (trim-and-fill corrected OR=1.25, 95%CI 0.97–1.62) and blood loss during pregnancy 
(trim-and-fill corrected OR=1.42, 95%CI 0.96–2.11). 
 
Labour & Delivery Factors (Table 3) 
Numerous labour and delivery complications were analysed, but a statistically significant risk 
factor association was found only for asphyxic state (OR=1.93). However, we detected 
potential publication bias for this factor (trim-and-fill corrected OR=1.36, 95%CI 0.90–2.07). 
 
Foetal Growth & Development Factors (Table 4) 
Lower birthweights were significant risk factors: <2000g (OR=1.84), <2500g (OR=1.53), 
2500–2999g (OR=1.23), while higher birthweights were statistically significant protective 
factors: 3500–3999g (OR=0.90) and >4000g (OR=0.86). In addition, birth length <49cm 
(OR=1.17), small for gestational age (OR=1.40), premature birth (OR=1.35) and congenital 
malformations (OR=2.35) were all statistically significant risk factors. We did not detect 
publication bias for any of these factors. 
 
Heterogeneity, Bias Assessment and Meta-Regressions 
High heterogeneity (I2>50%) was detected for several factors (see Tables 1–4), but forest 
plots showed that this heterogeneity was mostly due to some studies finding smaller effect 
sizes and other studies finding larger effect sizes in the same direction (eResults 1). The only 
exceptions where heterogeneity was due to studies finding opposite effect sizes were paternal 
age at delivery >35, maternal infections NOS, any famine/nutritional deficits, obstetric 
complications NOS and gestational age <37 weeks. Meta-regressions revealed that study risk 
of bias significantly accounted for 24% of the variance in obstetric complications NOS (better 
quality studies suggested a smaller OR), and 57% of the variance in winter season of birth in 
northern hemisphere (better quality studies suggested larger OR, eResults 2). Risk of bias 
scores are presented in eTable 4. 
 
Sensitivity Analyses 
Full sensitivity analyses are presented in eResults 3 and eTables 6–9. In brief, after excluding 
studies using retrospective recall, conclusions remained the same for 94 of the 98 original 
risk/protective factors, with the significance and direction of effects concordant with the main 
results. However, toxoplasma (OR=1.31, P=.14), maternal stress NOS (OR=2.05, P=.09) and 
ruptured membranes (all) (OR=1.58, P=.07) were no longer statistically significant risk factors. 
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There were not enough studies evaluating the need for incubator to conduct a sensitivity 




This study is the first comprehensive meta-analysis of prenatal and perinatal risk factors for 
psychotic disorders to be conducted in nearly 20 years19,22,23. Overall, 152 studies were 
included, contributing data on a total of 98 risk/protective factors. There were 30 significant 
risk factors: maternal ages <20 and 30–34 years, paternal age <20 and >35 years, any 
maternal or paternal psychopathology, maternal psychosis and affective disorder, ³3 
pregnancies, HSV-2, maternal infections NOS, suboptimal number of antenatal care visits, 
winter or winter/spring season of birth in northern hemisphere, maternal stress NOS, famine, 
any famine/nutritional deficits in pregnancy, maternal hypertension, hypoxia, ruptured and 
premature rupture of membranes, polyhydramnios, definite obstetric complications NOS9,44, 
birthweights <2000g, <2500g, 2500–2999g, birth length <49cm, small for gestational age, 
premature birth and congenital malformations. There were 5 significant protective factors: 
maternal ages 20–24 and 25–29, nulliparity, birthweights 3500–3999g and >4000g. These 
results were controlled for publication biases.   
 
The first overarching finding of the current meta-analysis is that the significant risk factors had 
ORs generally below 2, which is broadly consistent with the effect sizes reported in previous 
meta-analyses of this topic19,22,23 and indicates that they each modulate risk by a relatively 
small amount. Exceptions included any maternal or paternal psychopathology, maternal 
psychosis, affective disorder, maternal stress, premature rupture of membranes, 
polyhydramnios and congenital malformations. Protective factors were even weaker in 
magnitude, with the largest OR (birthweight >4000g) of only 0.86. These findings expand on 
the previous 2002 meta-analysis19, which synthesised data from 8 prospective population-
based studies with schizophrenia as the outcome. The current meta-analysis includes 152 
papers, conferring significantly higher power and some key differences: we (a) included both 
cohort and case-control studies, and (b) used a broader outcome definition (all non-organic 
psychotic disorder) to better inform clinical practice which is focused on early intervention in 
psychosis45,46 (eDiscussion). 
 
Within parental and familial factors, both young (<20 years) and later parental (30–34 
maternal; >35 paternal) age were risk factors for psychosis, while maternal ages 20–24 and 
25–29 were protective factors. Recent umbrella reviews demonstrate that paternal age >35 is 
a significant risk factor for psychosis27 and anxiety disorders32, and higher paternal ages are 
associated with autism spectrum disorder30. Conversely, only one primary study showed a 
significant association between maternal ages 30–34 and psychosis47, but most studies did 
have ORs slightly above 1. Maternal age 30–34 has also been associated with autism 
spectrum disorder in a recent umbrella review30. However, as noted in the Limitations, we 
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make no assumption that maternal and paternal ages—or any other two risk factors—are 
necessarily independent, and our ORs should be understood as the risk associated with each 
factor without adjusting for other variables. Relatedly, our finding that multiparity and nulliparity 
were risk and protective factors, respectively, should be viewed with caution, because while it 
is possible that the risk associated with multiparity acts, for example, through reduced 
allocation (share) of parental resources per offspring48 or lower socioeconomic status18,49, 
multiparity is also highly correlated with maternal and paternal age (see Limitations). 
 
Within pregnancy-related risk factors, suboptimal/fewer number of antenatal care visits 
emerged as risk factor. Fewer antenatal visits by mothers of offspring who later develop 
psychosis (vs those who do not) may underlie the higher prevalence of obstetric events in 
these individuals18,50. However, suboptimal number of antenatal visits may be a proxy for 
maternal ill health/psychopathology or disadvantaged socioeconomic status, which could 
affect provision or attendance at antenatal clinics or make compliance with antenatal 
advice/health behaviours more challenging18,50.  
 
Obstetric complications represent some of the longest-studied and best-replicated 
environmental risk factors for psychosis51, and foetal hypoxia and anoxia-related factors, 
where the foetal brain is deprived of oxygen, are among those most consistently implicated52-
54. Our meta-analysis confirmed that hypoxia and some related blood supply markers, such 
as premature rupture of membranes and maternal hypertension during pregnancy, are 
significant risk factors for psychosis19,23. Premature rupture of membranes was the strongest 
risk factor in a previous individual-patient data meta-analysis of obstetric factors for 
psychosis23. Two further related risk factors, asphyxia and blood loss during pregnancy, 
became non-significant in our analyses after adjusting for publication bias. Both of these 
factors were significant (and had larger ORs) in the previous meta-analysis19, where 3 and 6 
studies were included, respectively, compared to the 9 and 13 studies included in the current 
meta-analysis. A further pertinent limitation, particularly for hypoxia, relates to the markedly 
heterogeneous risk factor definitions used across studies. However, with only 6 studies 
included, it was not possible to parcellate into specific (and likely more proximal) definitions. 
Finally, despite the relatively large number of studies that have now investigated pre-
eclampsia (16 in our analyses), the results appear decidedly null, consistent with previous 
meta-analyses19,23.   
 
Although not evaluated in the previous meta-analysis19, famine and any nutritional 
deficits/famine also emerged as significant risk factors. However, it should be noted that the 
studies contributing to the ‘any nutritional deficits’ risk factor were assessing many different 
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nutritional deficits, which we could not separate out due to the low number of studies. While 
only 3 studies contributed to the famine summary effect, these were, at least, large cohorts 
from geographically and ethnically disparate settings21,55,56.   
 
Despite the strong historic interest in maternal prenatal infections and psychosis, it is 
somewhat surprising that we found significant associations only for HSV-2 and maternal 
infections NOS. Of note, we found no indication, when assessed for any time during pregnancy 
nor for individual trimesters, of a significant effect of influenza. There was some evidence for 
toxoplasma, but adjustment for publication bias (and sensitivity analyses) rendered it non-
significant. The teratogenic role of infective agents is well established57,58 and epidemiological 
evidence specifically implicates maternal infection in the aetiology of 
schizophrenia/psychosis59. However, a 2016 study of more than 2 million individuals found no 
association between maternal infection and nonaffective psychosis in offspring60. The 
association between maternal infection and offspring psychosis also varies by infection 
severity and foetal sex, with males at significantly higher risk61. Finally, studies varied in terms 
of ascertainment method, with a tendency for ecological vs serological ascertainment in earlier 
than more recent studies, respectively62. These factors could well contribute to a lack of 
significant effects in our meta-analysis. 
 
Further significant pregnancy-related risk factors included polyhydramnios and maternal 
stress, but maternal stress was no longer significant after sensitivity analyses63-65. The 
association between maternal stress and psychosis may implicate cortisol, although recent 
evidence found no association between maternal cortisol levels during pregnancy and 
offspring schizophrenia66. Finally, in line with previous work27, we found a small (OR=1.05) but 
significant association between winter/spring season of birth in northern hemisphere and 
psychosis. 
 
Within labour and delivery-related risk factors, only asphyxia showed some evidence of 
association but became non-significant after controlling for publication bias. Notably, 
emergency caesarean section and uterine atony—significant risk factors in the previous meta-
analysis19—were not supported in the present study. 
 
Within foetal growth and development factors, lower birthweights (<2000g, <2500g, 2500–
2999g) were significant risk factors while higher birthweights (>3500g) were significant 
protective factors. Birthweights <2000g and <2500g were significant risk factors in our recent 
umbrella review27 and in the previous meta-analysis19. However, the current point estimates 
are smaller than those previously reported19, particularly for birthweight <2000g (OR=1.84 vs 
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OR=3.89), which may be due to the significantly enhanced sample size in the current analyses 
(14 and 25 studies for <2000g and <2500g, respectively, compared to the previous 2 and 5 
studies) or our broader diagnostic outcome. Birthweight can modulate cognitive ability at age 
6–8 years67-69 and one population-based cohort study reported a significant linear trend of 
increasing odds ratios for psychosis with decreasing birth weights67, a pattern reflected by the 
current meta-analytic results. In contrast to the previous meta-analysis19, we found significant 
associations between prematurity, small birth length (<49cm) and being small for gestational 
age with later psychotic disorder. The processes linking foetal growth and development to 
psychosis risk remain undetermined, but metabolic or endocrine dysregulation, cellular stress 
and inflammation may be implicated58,67,70. For example, it has been claimed that a subset of 
some of the most significant genetic variants associated with schizophrenia converge on 
impaired placental biology and its response to cellular stress70. Activation of these 
schizophrenia genes in the placenta, particularly in male foetuses, has been associated with 
foetal growth restriction70. Separate work indicates that numerous pre- and perinatal risk 
factors, such as maternal infection and foetal hypoxia, may all lead to impaired foetal growth 
in those who later develop psychosis71. Finally, congenital malformations had the largest OR 
of all development-related risk factors, which was also identified by our recent umbrella review 
and the previous meta-analysis19, with markedly similar effect sizes27. 
  
Implications 
First, as discussed above, our results may be used as a starting point for advancing 
aetiopathological understanding and inform future research in this field. For example, the 
significance and magnitude of the risk factors that we identified could form the basis of an 
updated assessment scale for collecting prenatal and perinatal risk exposure information 
(eDiscussion). Second, the measures of association provided by this evidence synthesis could 
be used to develop multivariable psychosis risk prediction models34, which integrate the 
loading of several factors into prognostic tools72,73 (eDiscussion). Some risk factors identified 
here are not only associated with psychosis but also other psychiatric and 
neurodevelopmental disorders (eDiscussion)30-32, which may suggest that some risk factors 
are transdiagnostic74. Our results can therefore provide a benchmark for comparison of the 
magnitude of pre- and perinatal risk factors for psychosis with other disorders. A third 
implication is that our results can advance preventive strategies. To date, prevention of 
psychosis has predominantly focused on delivering psychosocial interventions45,75 to people 
with subthreshold symptoms76 of the disorder (i.e. indicated prevention77). Since recent 
evidence suggests that these are not fully effective78,79, preventive efforts could be expanded 
to the ‘pre-symptomatic’80,81 or potentially the prenatal stage51,82-84, targeting those with 
specific risk factors (i.e. selective prevention77). For example, selective outreach campaigns 
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(e.g. in at-risk women, such as mothers with psychosis) could be implemented to mitigate 
exposure to modifiable factors, such as suboptimal antenatal care, nutritional deficits and 
maternal infection46. While it is extremely unlikely that preventing exposure to any one (or 
combination of) these pre- and perinatal factors in isolation will prevent the development of 
psychosis, it is conceivable that the simultaneous prevention of multiple environmental risk 
factors could together confer a significant risk reduction51.  
 
Limitations 
First, significant heterogeneity was detected across a number of risk factors. When possible, 
we used meta-regression to explain it, finding that study risk of bias was a significant 
moderator for two factors. Second, it is extremely unlikely that individual pre- or perinatal 
complications are independent of each other but we make no such claim or causal 
assumption17,54,85,86 (eLimitations). In addition, we could not assess risk factors stratified by 
potentially important factors, such as foetal sex, because most primary studies did not report 
data separately by such factors. Finally, exposure ascertainment may be subject to recall bias 
in those studies using retrospective recall after the outcome (i.e. psychosis) is known. We 
mitigated this limitation by conducting sensitivity analyses after removing the studies based 
on retrospective recall, with little change to the results. 
 
Conclusions 
We found numerous prenatal and perinatal risk factors to be associated with psychotic 
disorders. This knowledge advances understanding of psychosis, will facilitate multivariable 
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Table 1. Meta-Analytic Association between Parental and Familial Factors and Psychotic Disorders 
Risk Factor 
N  Odds Ratio  Heterogeneity  Publication Bias 
Studies Samples  Value 95% CI P  I2 (%) P  Funnel Plot Asymmetrya 
Trim & Fill 
imputed 
studies 





PARENTAL & FAMILIAL 
FACTORS  
  




    
Parental age               
Maternal age at delivery (years):               
<20 22 22  1.17 1.07 – 1.27 <.001  19 .21  No 0 NA .81 
20–24 20 20  0.93 0.89 – 0.96 <.001  0 .83  No 0 NA .48 
25–29 21 21  0.92 0.88 – 0.95 <.001  5 .40  No 0 NA .40 
30–34 20 20  1.05 1.01 – 1.09 .02  0 .83  No 0 NA .72 
35+ 24 24  1.44 0.98 – 2.12 .06  99 <.001  Poss. (right) 0 NA .51 
Paternal age at delivery (years):               
<20 11 11  1.31 1.17 – 1.46 <.001  0 .74  Poss. (right) 0 NA .45 
20–24 12 12  0.97 0.91 – 1.04 .45  25 .19  No 0 NA .54 
25–29 12 12  0.96 0.83 – 1.11 .57  92 <.001  No 0 NA .79 
30–34 12 12  0.97 0.94 – 1.00 .06  0 .98  No 0 NA .72 
35+ 13 13  1.28 1.06 – 1.55 .01  97 <.001  Poss. (right) 0 NA .18 
Pregnancy history               
Parity/previous pregnancies:                
0 (nulliparous) 10 10  0.91 0.85 – 0.97 .004  0 .99  Poss. (left) 1 0.91 (0.85 – 0.97) .46 
1 8 8  1.05 0.79 – 1.40 .72  81 <.001  Yes (right) 0 NA .92 
2 7 7  0.92 0.82 – 1.03 .15  0 1.00  No 0 NA .95 
3 or more 10 10  1.30 1.16 – 1.45 <.001  0 .54  Poss. (right) 0 NA .46 
First born (vs other) 8 8  0.94 0.70 – 1.26 .68  53 .04  No 0 NA .95 
Twin (or multiple) birth 5 5  0.65 0.43 – 1.00 .05  25 .26  Poss. 0 NA .77 
Familial psychopathology               
Any maternal psychopathology 9 9  4.60 2.74 – 7.73 <.001  97 <.001  Poss. (right) 0 NA .13 
Maternal psychosis 6 6  7.61 6.29 – 9.21 <.001  62 .02  Yes (right) 1 7.49 (6.23 – 9.00) .19 
Maternal affective disorder 3 3  2.26 1.09 – 4.70 .03  90 <.001  No 0 NA .91 
Any paternal psychopathology 5 5  2.73 2.33 – 3.19 <.001  27 .24  Yes (left) 3 2.56 (2.20 – 2.97) .06 
 
 25 
All summary effects estimated using random-effects meta-analyses. N: number of studies and samples (where studies included more than one sample/independent 
cohort); NA, not applicable OR, odds ratio; P, p value (2-tailed); Poss., possible. OR > 1 indicates risk factor and OR < 1 indicates protective factor; I2 > 50% indicates 
serious heterogeneity; asymmetry in the funnel plot and imputed studies in the trim and fill indicate potential publication bias. 
a Results of visual inspection for funnel plot asymmetry (yes, no, possible [Poss.]) and the side where studies are potentially missing (left, right). 
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Table 2. Meta-Analytic Association between Pregnancy Factors and Psychotic Disorders 
Risk Factor 
N  Odds Ratio  Heterogeneity  Publication Bias 
Studies Samples  Value 95% CI P  I2 ( %) P  Funnel Plot Asymmetrya 
Trim & Fill 
imputed 
studies 





PREGNANCY FACTORS  
  




    
Maternal medical conditions/ procedures               
Maternal diabetes in pregnancy 3 3  5.13 0.83 – 31.53 .08  20 .29  Poss. (left) 0 NA .72 
Admission to hospital during pregnancy 3 5  0.97 0.66 – 1.42 .88  79 <.001  Yes (right) 0 NA .08 
Fever in pregnancy 3 3  2.18 0.85 – 5.57 .10  0 .69  Yes (left) 2 1.42 (0.67 – 3.02) .79 
Suboptimal no. antenatal care visits 4 4  1.83 1.42 – 2.36 <.001  0 .73  Poss. (right) 0 NA .06 
Infective agents               
Toxoplasma 4 4  1.30 1.04 – 1.62 .02  18 .30  Yes (left) 1 1.25 (0.98 – 1.58) .47 
Herpes simplex type 1 4 4  0.97 0.75 – 1.26 .82  0 .86  Poss. (right) 0 NA .99 
Herpes simplex type 2 5 5  1.35 1.16 – 1.58 <.001  0 .80  No 0 NA .77 
Unspecified maternal infections NOS 9 9  1.27 1.06 – 1.53 .01  50 .04  Yes (left) 1 1.26 (1.04 – 1.52) .93 
Influenza infection               
Any time during pregnancy 8 8  1.13 0.94 – 1.35 .20  52 .04  Yes (left) 3 1.03 (0.83 – 1.29) .03 
First trimester 6 6  1.36 0.79 – 2.35 .27  44 .11  Yes (left) 2 1.08 (0.58 – 2.00) .07 
Second trimester 5 5  1.04 0.92 – 1.18 .55  0 .58  Poss. (left) 1 1.03 (0.88 – 1.20) .60 
Third trimester 4 4  1.37 0.91 – 2.06 .13  0 .85  No 0 NA .96 
Cytomegalovirus 3 3  1.09 0.80 – 1.48 .60  0 .74  No 0 NA .82 
Urinary tract infection 4 6  0.99 0.68 – 1.44 .95  0 .69  Yes (left) 1 0.90 (0.64 – 1.29) .86 
Sexually transmitted infections 3 3  1.51 0.58 – 3.89 .40  58 .10  Poss. (right) 0 NA .97 
Maternal drug use during pregnancy               
Smoking 8 8  1.29 0.88 – 1.90 .19  71 <.01  Yes (left) 2 1.08 (0.69 – 1.68) .74 
Alcohol 6 6  1.76 0.71 – 4.37 .22  42 .13  Poss. (left) 1 1.50 (0.59 – 3.78) .88 
Maternal stress during pregnancy               
Death/severe illness of a close relative 3 3  0.84 0.61 – 1.17 .31  0 .45  No 0 NA .40 
Exposure to catastrophic event:               
Any time during pregnancy 5 6  1.15 0.98 – 1.36 .09  74 .002  Poss. (left) 0 NA .30 




N  Odds Ratio  Heterogeneity  Publication Bias 
Studies Samples  Value 95% CI P  I2 ( %) P  Funnel Plot Asymmetrya 
Trim & Fill 
imputed 
studies 





Second trimester 4 4  1.03 0.91 – 1.18 .64  0 .76  Yes (left) 1 1.03 (0.90 – 1.17) .88 
Third trimester 4 4  1.02 0.90 – 1.16 .79  0 .89  Yes (left) 1 1.02 (0.90 – 1.15) .98 
Maternal stress NOS 4 4  2.40 1.15 – 5.01 .02  80 .002  Poss. (left) 0 NA .09 
Famine & nutritional deficits               
Any famine/nutritional deficits 11 13  1.40 1.17 – 1.68 <.001  69 <.001  Yes (left) 1 1.38 (1.14 – 1.67) .60 
Famine 3 3  1.61 1.51 – 1.71 <.001  0 .46  Yes (left) 1 1.60 (1.50 – 1.70) .63 
Maternal anaemia 4 6  0.92 0.61 – 1.40 .71  30 .21  Yes (left) 1 0.87 (0.58 – 1.32) .39 
Maternal haemoglobin:               
<10 g/dl 3 3  1.04 0.49 – 2.23 .92  81 .005  Poss. 0 NA .15 
>12 g/dl 3 3  1.05 0.60 – 1.83 .87  75 .02  Poss. 0 NA .29 
Pregnancy complications               
Maternal hypertension 5 7  1.40 1.10 – 1.78 .006  0 .74  Yes (left) 2 1.38 (1.09 – 1.74) .77 
Pre-eclampsia/toxaemia 14 16  1.32 0.99 – 1.76 .06  26 .16  Poss. (left) 1 1.29 (0.96 – 1.72) .62 
Hypoxia (as defined by authors) 6 6  1.63 1.11 – 2.40 .01  41 .13  No 0 NA .48 
Ruptured membranes (all) 5 7  1.86 1.23 – 2.83 .003  0 .77  Yes (right) 0 NA .11 
Preterm rupture 1 3  1.20 0.58 – 2.51 .62  0 .86  No 0 NA .74 
Premature rupture 4 4  2.29 1.38 – 3.80 .001  0 .80  Yes (left) 1 2.13 (1.38 – 3.30) .35 
Polyhydramnios 3 3  3.05 1.15 – 8.06 .02  0 1.0  No 0 NA .40 
Blood loss during pregnancy 11 13  1.54 1.06 – 2.25 .02  33 .12  Poss. (left) 1 1.42 (0.96 – 2.11) .86 
Unspecified obstetric complications (NOS) 19 21  1.52 1.19 – 1.94 <.001  67 <.001  Yes (left) 5 1.25 (0.97 – 1.62) .06 
“Definite” obstetric complications NOSb 9 9  1.83 1.21 – 2.77 .004  71 <.001  Yes (left) 0 NA .002 
Placental complications 5 5  1.52 0.42 – 5.43 .52  60 .04  No 0 NA .46 
Rhesus-related factors/ incompatibility 9 9  1.42 1.00 – 2.01 .05  0 .44  Yes (left) 3 1.32 (0.91 – 1.91) .15 
Season of birth in northern hemisphere:               
Winter/spring 8 8  1.05 1.03 – 1.08 <.001  77 <.001  Poss. (left) 2 1.04 (1.02 – 1.07) .72 
Winter 11 11  1.05 1.03 – 1.08 <.001  55 .01  Poss. (right) 0 NA .49 
All summary effects estimated using random-effects meta-analyses. N: number of studies and samples (note that some studies included more than one 
sample/independent cohort); NA, not applicable OR, odds ratio; P, p value (2-tailed); Poss., possible. OR > 1 indicates risk factor and OR < 1 indicates protective factor; I2 
> 50% indicates serious heterogeneity; asymmetry in the funnel plot and imputed studies in the trim and fill indicate potential publication bias. 
a Results of visual inspection for funnel plot asymmetry (yes, no, possible [Poss.]) and the side where studies are potentially missing (left, right). 
b “Definite” obstetric complications as specified in the Lewis-Murray Obstetric Complications Scale. 
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Table 3. Meta-Analytic Association between Labour and Delivery Factors and Psychotic Disorders 
Risk Factor 
N  Odds Ratio  Heterogeneity  Publication Bias 
Studies Samples  Value 95% CI P  I2 (%) P  Funnel Plot Asymmetrya 
Trim & Fill 
imputed 
studies 





LABOUR & DELIVERY FACTORS  
  




    
Labour and delivery complications               
Caesarean section (any)  12 14  1.13 0.90 – 1.43 .30  42 .05  Yes (left) 5 1.00 (0.78 – 1.29) .15 
Caesarean section (emergency)  9 9  1.41 0.87 – 2.30 .16  39 .11  Yes (left) 4 0.98 (0.61 – 1.57) .06 
Prolonged duration of labour 11 13  1.30 0.92 – 1.83 .14  47 .04  No 0 NA .54 
Induced labour:               
Oxytocics 2 4  1.01 0.81 – 1.27 .91  0 .58  Yes (left) 1 0.96 (0.78 – 1.19) (<).05 
Artificial rupture of membranes 2 4  1.11 0.78 – 1.57 .57  61 .05  Yes (left) 1 0.99 (0.70 – 1.42) .45 
Forceps, vacuum, instrumental delivery 14 16  1.15 0.91 – 1.46 .25  40 .05  Yes (left) 6 0.98 (0.75 – 1.27) .02 
Abnormal presentation:               
Non-vertex 10 12  1.03 0.77 – 1.39 .83  12 .33  Yes (left) 3 0.89 (0.62 – 1.28) .15 
Breech 5 5  1.00 0.52 – 1.94 .99  0 .54  No 0 NA .50 
Cephalopelvic disproportion 3 5  1.07 0.58 – 1.97 .83  21 .28  Poss. (right) 0 NA .99 
Baby detained in hospital/special care 3 5  1.06 0.72 – 1.57 .76  62 .03  Poss. (right) 0 NA .23 
Nonspontaneous delivery 3 5  0.98 0.78 – 1.24 .89  0 .46  Yes (left) 1 0.95 (0.76 – 1.18) .53 
Uterine atony 3 3  2.37 0.79 – 7.12 .12  39 .20  No 0 NA .99 
Apgar score <7 at 5 mins 5 5  1.57 0.94 – 2.63 .08  0 .45  Yes (left) 2 1.35 (0.75 – 2.43) .14 
Umbilical cord complications (any) 7 7  1.13 0.93 – 1.39 .22  0 .73  Yes (left) 2 1.11 (0.91 – 1.36) .10 
Umbilical cord around neck 4 4  1.11 0.90 – 1.37 .32  0 .66  No 0 NA .79 
Abnormal foetal heart rate/rhythm 3 3  1.17 0.80 – 1.73 .42  0 .40  Yes (left) 2 0.93 (0.62 – 1.39) .11 
Asphyxic state 8 9  1.93 1.30 – 2.88 .001  43 .08  Yes (left) 5 1.36 (0.90 – 2.07) .07 
Maternal blood loss during delivery 3 3  1.12 0.27 – 4.73 .88  61 .07  No 0 NA .47 
All summary effects estimated using random-effects meta-analyses. N: number of studies and samples (note that some studies included more than one 
sample/independent cohort); NA, not applicable OR, odds ratio; P, p value (2-tailed); Poss., possible. OR > 1 indicates risk factor and OR < 1 indicates protective factor; I2 
> 50% indicates serious heterogeneity; asymmetry in the funnel plot and imputed studies in the trim and fill indicate potential publication bias. 





Table 4. Meta-Analytic Association between Foetal Growth and Development Factors and Psychotic Disorders 
Risk Factor 
N  Odds Ratio  Heterogeneity  Publication Bias 
Studies Samples  Value 95% CI P  I2 (%) P  Funnel Plot Asymmetrya 
Trim & Fill 
imputed 
studies 





FOETAL GROWTH & 
DEVELOPMENT  
  




    
Gestational age:               
<37 weeks (premature birth) 21 24  1.35 1.12 – 1.62 .002  58 <.001  Poss. (left) 0 NA .37 
>42 weeks 10 12  1.14 0.96 – 1.35 .13  25 .19  Yes (left) 1 1.13 (0.96 – 1.32) .35 
Neonate birth weight & size               
Birthweight:               
<2000g 13 14  1.84 1.53 – 2.22 <.001  0 .83  No 0 NA .95 
<2500g 23 25  1.53 1.31 – 1.78 <.001  25 .13  No 0 NA .46 
2500–2999g 15 17  1.23 1.15 – 1.31 <.001  0 .92  Poss. (left) 0 NA .15 
3000–3499g 15 17  1.00 0.95 – 1.05 .92  0 .99  Poss. (left) 0 NA .62 
3500–3999g 15 17  0.90 0.85 – 0.94 <.001  0 .99  No 0 NA .99 
>4000g 15 17  0.86 0.80 – 0.92 <.001  0 76  Yes (left) 2 0.85 (0.80 – 0.92) .29 
<2500g & premature 4 4  1.53 0.90 – 2.60 .12  13 .33  Poss. (right) 0 NA .04 
Low ponderal index (≤5th centile) 2 4  1.17 0.82 – 1.67 .38  6 .36  No 0 NA .79 
High ponderal index (≥95th centile) 2 4  1.13 0.80 – 1.60 .47  0 .79  Poss. (right) 0 NA .18 
Small for gestational age 10 12  1.40 1.25 – 1.57 <.001  18 .26  No 0 NA .97 
Large/heavy for gestational age 3 3  1.10 0.75 – 1.61 .62  44 .17  No 0 NA .64 
Birth length <49cm  8 8  1.17 1.05 – 1.32 .01  21 .27  Yes (left) 3 1.15 (1.03 – 1.29) .07 
Birth length >54cm 7 7  1.03 0.83 – 1.28 .77  0 .79  Yes (left) 2 1.02 (0.82 – 1.26) .17 
Head circumference <32cm 10 10  1.37 0.99 – 1.91 .06  14 .31  Yes (left) 5 1.22 (0.88 – 1.69) .04 
Neonatal Health               
Congenital malformation 4 4  2.35 1.23 – 4.46 .009  0 .82  Yes (left) 1 2.26 (1.22 – 4.18) .80 
Need for incubator 3 3  2.54 0.69 – 9.69 .16  0 .43  No 0 NA .77 
All summary effects estimated using random-effects meta-analyses. N: number of studies and samples (note that some studies included more than one 
sample/independent cohort); NA, not applicable OR, odds ratio; P, p value (2-tailed); Poss., possible. OR > 1 indicates risk factor and OR < 1 indicates protective factor; I2 
> 50% indicates serious heterogeneity; asymmetry in the funnel plot and imputed studies in the trim and fill indicate potential publication bias. 
a Results of visual inspection for funnel plot asymmetry (yes, no, possible [Poss.]) and the side where studies are potentially missing (left, right). 
